A detailed history of Sunbelt Securities, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Sunbelt Securities, Inc. holds 15,703 shares of GILD stock, worth $1.43 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
15,703
Previous 15,678 0.16%
Holding current value
$1.43 Million
Previous $1.08 Million 22.42%
% of portfolio
0.14%
Previous 0.12%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 18, 2024

BUY
$66.59 - $83.99 $1,664 - $2,099
25 Added 0.16%
15,703 $1.32 Million
Q2 2024

Aug 15, 2024

BUY
$63.15 - $72.88 $257,336 - $296,986
4,075 Added 35.12%
15,678 $1.08 Million
Q1 2024

Apr 15, 2024

BUY
$71.58 - $87.29 $173,653 - $211,765
2,426 Added 26.44%
11,603 $849,000
Q4 2023

Feb 14, 2024

BUY
$73.27 - $83.09 $5,421 - $6,148
74 Added 0.81%
9,177 $743,000
Q3 2023

Dec 11, 2023

SELL
$73.94 - $80.67 $14,270 - $15,569
-193 Reduced 2.08%
9,103 $682,000
Q2 2023

Aug 15, 2023

BUY
$76.01 - $86.7 $35,116 - $40,055
462 Added 5.23%
9,296 $716,000
Q1 2023

May 17, 2023

BUY
$77.31 - $88.08 $2,551 - $2,906
33 Added 0.37%
8,834 $732,000
Q4 2022

Feb 08, 2023

BUY
$62.32 - $89.47 $12,027 - $17,267
193 Added 2.24%
8,801 $755,000
Q3 2022

Nov 21, 2022

BUY
$59.54 - $68.01 $28,519 - $32,576
479 Added 5.89%
8,608 $531,000
Q2 2022

Oct 03, 2022

BUY
$57.72 - $65.01 $5,310 - $5,980
92 Added 1.14%
8,129 $502,000
Q1 2022

May 16, 2022

SELL
$57.92 - $72.58 $60,989 - $76,426
-1,053 Reduced 11.58%
8,037 $479,000
Q4 2021

Feb 14, 2022

BUY
$64.88 - $73.64 $34,840 - $39,544
537 Added 6.28%
9,090 $579,000
Q2 2021

Jul 29, 2021

SELL
$63.47 - $69.35 $626,766 - $684,831
-9,875 Reduced 53.59%
8,553 $587,000
Q1 2021

May 27, 2021

BUY
$60.0 - $68.46 $605,100 - $690,419
10,085 Added 120.88%
18,428 $1.19 Million
Q4 2020

Feb 09, 2021

BUY
$56.65 - $64.55 $7,647 - $8,714
135 Added 1.64%
8,343 $486,000
Q3 2020

Nov 17, 2020

SELL
$62.1 - $78.08 $5,464 - $6,871
-88 Reduced 1.06%
8,208 $519,000
Q2 2020

Aug 14, 2020

BUY
$72.34 - $84.0 $289 - $336
4 Added 0.05%
8,296 $640,000
Q1 2020

May 15, 2020

SELL
$62.63 - $80.22 $699,201 - $895,576
-11,164 Reduced 57.38%
8,292 $620,000
Q4 2019

Feb 14, 2020

SELL
$61.62 - $67.78 $43,873 - $48,259
-712 Reduced 3.53%
19,456 $316 Million
Q3 2019

Nov 15, 2019

BUY
$62.51 - $69.0 $624,849 - $689,724
9,996 Added 98.27%
20,168 $1.28 Million
Q2 2019

Aug 01, 2019

BUY
$61.87 - $69.38 $134,196 - $150,485
2,169 Added 27.1%
10,172 $687,000
Q1 2019

May 15, 2019

BUY
$62.53 - $70.05 $28,576 - $32,012
457 Added 6.06%
8,003 $520,000
Q4 2018

Feb 14, 2019

SELL
$60.54 - $79.0 $29,180 - $38,078
-482 Reduced 6.0%
7,546 $472,000
Q3 2018

Nov 14, 2018

SELL
$71.28 - $78.92 $5,488 - $6,076
-77 Reduced 0.95%
8,028 $620,000
Q2 2018

Aug 08, 2018

BUY
$64.88 - $75.68 $62,674 - $73,106
966 Added 13.53%
8,105 $574,000
Q1 2018

May 09, 2018

SELL
$72.84 - $88.8 $7,065 - $8,613
-97 Reduced 1.34%
7,139 $538,000
Q4 2017

Feb 06, 2018

BUY
$71.15 - $83.52 $514,841 - $604,350
7,236
7,236 $518,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $114B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Sunbelt Securities, Inc. Portfolio

Follow Sunbelt Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sunbelt Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sunbelt Securities, Inc. with notifications on news.